17.04.2024 11:58 | RENE | ReNeuron CFO steps down to pursue other opportunities | Alliance |
17.04.2024 11:30 | RENE | Directorate Change | RNS |
20.03.2024 18:11 | CDL, DSM, RENE | TRADING UPDATES: ReNeuron appoints administrators as rescue talks fail | Alliance |
20.03.2024 15:43 | RENE | Appointment of Administrators | RNS |
20.03.2024 12:30 | RENE | Intention to Appoint Administrators | RNS |
01.03.2024 07:00 | RENE | Block Listing Review & Total Voting Rights | RNS |
05.02.2024 20:23 | ENET, TRR, CLON | TRADING UPDATES: ReNeuron warns; Gama Aviation pledges cash return | Alliance |
05.02.2024 14:30 | RENE | Corporate update and suspension of trading on AIM | RNS |
05.02.2024 14:30 | RENE | Suspension - ReNeuron Group plc | RNS |
27.11.2023 08:53 | RENE | Edison issues update on ReNeuron Group (RENE): H124 results reaffirm focus on CustomEX™ | EQS |
08.11.2023 12:21 | RENE | ReNeuron interim loss narrows on lower costs; eyes partnerships | Alliance |
04.09.2023 10:24 | RENE | IN BRIEF: ReNeuron makes progress on exosome delivery platform | Alliance |
15.08.2023 15:45 | STM, RUA, RENE | UK shareholder meetings calendar - next 7 days | Alliance |
18.05.2023 15:03 | YNGA, WKP, VANQ | UK earnings, trading statements calendar - next 7 days | Alliance |
19.01.2023 14:29 | RENE | IN BRIEF: ReNeuron reduces headcount by 40%; to focus on CustomEX data | Alliance |
03.01.2023 11:21 | RENE | ReNeuron Chair Iain Ross moves to executive chair as CEO departs | Alliance |
02.12.2022 10:40 | OMI, TERN, PMI | AIM WINNERS & LOSERS: Orosur Mining drops on disappointing assays | Alliance |
02.12.2022 09:31 | RENE | ReNeuron loss narrows amid lower costs and surging revenue | Alliance |
07.10.2022 10:32 | RENE | ReNeuron says exosomes outperform alternatives at Boston summit | Alliance |
14.09.2022 13:19 | RENE | IN BRIEF: ReNeuron promotes Financial Controller Hawkins to CFO | Alliance |
02.09.2022 15:57 | SVM, RENE, PRE | UK shareholder meetings calendar - next 7 days | Alliance |
01.08.2022 14:30 | ARBB, TRLS, SDY | EXECUTIVE CHANGES: ReNeuron promotes CFO Catherine Isted to CEO role | Alliance |
04.07.2022 10:22 | RENE | IN BRIEF: ReNeuron annual loss narrows amid shift in strategy | Alliance |
01.07.2022 13:40 | RENE | IN BRIEF: ReNeuron inks deal worth up to GBP6 million in revenue | Alliance |
27.06.2022 15:53 | RENE, PRV, AUGM | UK earnings, trading statements calendar - next 7 days | Alliance |
11.02.2022 13:50 | RENE | IN BRIEF: ReNeuron chair steps in to run business as CEO resigns | Alliance |
16.09.2021 16:26 | RENE | Result of AGM | RNS |
02.09.2021 12:00 | RENE | Block Listing Review, Application and TVR | RNS |
16.08.2021 14:20 | RENE | Posting of AR and Accounts and Notice of AGM | RNS |
06.08.2021 07:00 | RENE | Directorate Change | RNS |
14.07.2021 07:00 | RENE | Board Change | RNS |
08.07.2021 07:00 | RENE | Preliminary Results for the year ended 31 March 21 | RNS |
02.07.2021 13:00 | RENE | Notice of Results | RNS |
02.07.2021 07:00 | RENE | Notice of Results | RNS |
01.07.2021 07:00 | RENE | Directorate Change | RNS |
18.06.2021 10:48 | RENE | Holding(s) in Company | RNS |
09.06.2021 16:36 | RENE | Price Monitoring Extension | RNS |
09.06.2021 14:05 | RENE | Second Price Monitoring Extn | RNS |
09.06.2021 14:00 | RENE | Price Monitoring Extension | RNS |
09.06.2021 11:55 | RENE | Update for hRPC therapy candidate study | RNS |
07.06.2021 17:25 | RENE | Holding(s) in Company | RNS |
20.05.2021 07:00 | RENE | Appointment of Chief Scientific Officer | RNS |
04.05.2021 07:00 | RENE | Total Voting Rights | RNS |
29.04.2021 07:00 | RENE | Initiation of research by Allenby Capital | Reach |
06.04.2021 07:00 | RENE | Virtual conference attendance and presentations | Reach |
30.03.2021 07:00 | RENE | Holding(s) in Company | RNS |
19.03.2021 07:00 | RENE | Exosome platform update | RNS |
16.03.2021 16:05 | SDR, RENE | Holding(s) in Company | RNS |
16.03.2021 10:57 | RENE | Holding(s) in Company | RNS |
16.03.2021 07:00 | RENE | Holding(s) in Company | RNS |
12.03.2021 07:00 | RENE | Directorate Change | RNS |
01.03.2021 07:00 | RENE | Block Listing Review and Total Voting Rights | RNS |
25.02.2021 07:01 | RENE | Investor presentations | Reach |
25.02.2021 07:00 | RENE | Appointment of Joint Broker | RNS |
11.02.2021 07:00 | RENE | Director/PDMR Interest in Shares and Share Options | RNS |
01.02.2021 09:55 | RENE | Total Voting Rights | RNS |
15.01.2021 14:06 | RENE | Second Price Monitoring Extn | RNS |
15.01.2021 14:01 | RENE | Price Monitoring Extension | RNS |
15.01.2021 07:00 | RENE | Clinical Update | RNS |
06.01.2021 07:00 | RENE | Analyst Conference Call | Reach |